Jaan Acquires Bio Healthcare Research Institute... "Secures Patent Technologies Including Anti-inflammatory Peptides"

[Asia Economy Reporter Hyunseok Yoo] Jaan announced on the 22nd that it has acquired the bio research facilities and related patents of a domestically listed cosmeceutical specialized company through an asset transfer method to revitalize its bio healthcare business.

The bio research institute acquired this time is researching and developing cosmeceutical raw materials based on peptide substances. It holds a total of nine peptide-related patents, including 'Epithelial Growth Factor Composition and Wound Treatment' and 'New Peptides with Anti-inflammatory Activity,' and the related patents were transferred to Jaan on the 19th.

Based on the peptide patents, Jaan plans to develop health functional foods such as anti-inflammatory, wrinkle improvement, and hair loss prevention, and produce products through OEM and ODM methods. Centered on its recently launched healthcare platform 'SelecOn Health,' it plans to actively expand not only to various domestic distribution channels but also to overseas markets.

A Jaan official said, "Following the partnership contract with 'Bio Pharma Research Lab' in December last year, the acquisition of this bio research institute will greatly strengthen Jaan's own research capabilities," adding, "We plan to develop raw materials in the 'low molecular peptide' category, which can maximize the efficacy of raw materials due to high absorption rates in the body, as well as conduct research on secondary metabolites of organisms, in addition to health functional foods."

He continued, "The joint research agreement currently underway is also expected to be completed soon, completing the establishment of our own research and development infrastructure for the new bio healthcare business," and added, "Based on Jaan's marketing, branding, and global sales capabilities, sales and profits of the new product lines are expected to grow significantly."

Meanwhile, to revitalize its bio healthcare business, Jaan opened the global bio healthcare distribution platform 'SelecOn Health' in December last year and secured exclusive distribution rights for the UK health functional food specialized brand 'ProWise Healthcare.'

This content was produced with the assistance of AI translation services.